Terumo Will Top Blood Transfusion Device Space With $2.6 Billion Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Diversified Japanese device maker Terumo will become the global leader in the blood transfusion product market with its planned $2.6 billion acquisition of privately owned CaridianBCT.